Found: 6
Select item for more details and to access through your institution.
Machine learning–based integration of network features and chemical structure of compounds for SARS‐CoV‐2 drug effect analysis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 2, p. 257, doi. 10.1002/psp4.13076
- By:
- Publication type:
- Article
dsMTL: a computational framework for privacy-preserving, distributed multi-task machine learning.
- Published in:
- Bioinformatics, 2022, v. 38, n. 21, p. 4919, doi. 10.1093/bioinformatics/btac616
- By:
- Publication type:
- Article
Privacy-aware multi-institutional time-to-event studies.
- Published in:
- PLoS Digital Health, 2022, v. 1, n. 9, p. 1, doi. 10.1371/journal.pdig.0000101
- By:
- Publication type:
- Article
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.
- Published in:
- NPJ Systems Biology & Applications, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41540-022-00214-z
- By:
- Publication type:
- Article
Flimma: a federated and privacy-aware tool for differential gene expression analysis.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02553-2
- By:
- Publication type:
- Article
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17189-2
- By:
- Publication type:
- Article